An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80 mg and Amlodipine 5 mg and Hydrochlorothiazide 12.5 mg vs. Telmisartan 80 mg and Amlodipine 5 mg in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg and Amlodipine 5 mg
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Apr 2014 Planned End Date changed from 1 Aug 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 30 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.